GE forms colorectal cancer pact:
This article was originally published in Clinica
Executive Summary
GE Healthcare has joined forces with the University of Oxford in the UK in a research programme designed to improve the diagnosis and treatment of colorectal cancer. The two-year collaboration, which will combine GE's knowledge of genomic and information technologies with the university's clinical data and medical and research expertise, will focus on improving colorectal cancer staging using imaging and genomic pathology; targeted therapy selection and efficacy assessment; and overall treatment monitoring. Results of the study could act as a model for other cancers and diseases.